Navigation Links
SemBioSys provides update on insulin program
Date:4/1/2009

CALGARY, April 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, provides an update on its proprietary plant-produced recombinant human insulin program. In December 2008, SemBioSys announced that MannKind Corporation purchased a non-refundable option to license rights to SemBioSys' proprietary plant-produced recombinant human insulin to be used primarily for AFRESA(TM), MannKind's ultra-rapid acting insulin product. At the time the option was taken, MannKind had completed diligence related to the SemBioSys insulin program and final written agreements had been prepared for execution, were the option to be exercised. In March 2009, MannKind announced that it had entered into agreements with Pfizer Inc. "to purchase Pfizer's insulin facility at Industriepark Hoechst, Frankfurt am Main, Germany and assets related to the production of bulk insulin, including the relevant real property rights, the production equipment, a quantity of bulk insulin and a license to manufacture bulk insulin for use in pulmonary delivery." The option period for SemBioSys' agreement with MannKind expired yesterday without action and SemBioSys is now free to execute agreements relating to its insulin program with other parties.

Also in March 2009, SemBioSys reported results from the Phase I/II trial of its recombinant human insulin (SBS-1000) in human volunteers. SBS-1000 was shown to be bioequivalent to Eli Lilly's Humulin(R) R, a widely-used human insulin in North America.

"Based on prior discussions with third parties, we believe that our recent clinical trial results position us well to continue and expand our partnership discussions," said James Szarko, Chief Executive Officer of SemBioSys. "While the MannKind option was attractive from a timing point of view, and provided a valuable cash infusion, additional partnering options may be open to us now that we have positive clinic
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
2. SemBioSys announces senior management changes
3. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
4. SemBioSys begins phase I/II trial of insulin produced in plant seeds
5. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
6. SemBioSys announces second quarter 2008 financial and operational results
7. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
8. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
9. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
10. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
11. SemBioSys announces first quarter 2008 financial and operational results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-Asia...e "Company") (NYSE: SCR ), a leading pharmaceuti...acturing, and marketing of branded,generic and pro... that 105 of,its drugs have been included in China...h was issued by China,s Ministry of Human Resource...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- T...kets are in turmoil and uncertainty is part of man... pharma industry has been,relatively immune to the...,vacation. , During the midst of the diff...hnson & Johnson inaugurated an R&D center ...
(Date:12/2/2009)..., HOBOKEN, N.J., Dec. 2 Accordi... to 45 percent of Americans diagnosed with diabete... Diabetic retinopathy, damage to the retina cause...dness in people with diabetes and is one of the mo...80 percent of all patients who,ve had diabetes for...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-First...) today announced revenue guidance for the fourth ...57 million, as compared with $69 million for the f...2008 results was the first of two installment paym... in fourth quarter 2008 results was a one-time $1....
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... article, Michael Rosen argues that Big Pharma "w...gests that this will be a good thing. But Big Phar...onal pharmaceuticals. This strategy has not been p...ne will be well-served if Big Pharma adopts this s... if at least some "biogenerics" eventually are app...
... you learn a lot of things. , ,You learn that most...he Hitchhikers Guide to the Galaxy and their faith...hies like Linux and hate Microsoft. Among many oth...hies how they really, really feel about technology...ourself, you may have had a taste of the take by t...
...e investor group that has weathered a couple of sl...ip of tech entrepreneur Pehr Anderson. , ,The ange...gh net worth, allows investors to pool strategies,...ments. It began in 2000 with 13 investors, and aft...ade fewer deals over the last two years. , ,Anders...
Other Biology Technology:Big Pharma already has a generic strategy, but needs new direction 2Big Pharma already has a generic strategy, but needs new direction 3How to tackle the divide between techies and non-techies at work 2How to tackle the divide between techies and non-techies at work 3How to tackle the divide between techies and non-techies at work 4Boston entrepreneur to enliven Milwaukee angel group 2
(Date:12/1/2009)...n-Ari, winner of the 2009 Inserm Grand Prix., Ev...tment to paying tribute to outstanding,work perfo...ring talents, Inserm intends to,demonstrate the d...y,s biological, medical and,health research, and ...o carry out and,drive this research each day. The...
(Date:12/1/2009)...first, a Monash University-led international resea...the output of the next generation of solar cells. ...ion with colleagues from the universities of Wollo...-sensitised solar cells with a three-fold increase...viously reported tandem dye-sensitised solar cells...
(Date:12/1/2009)... like a bad cold, can spread among groups of peopl...ersity of California-San Diego and Harvard shows.,...y that has been following health conditions for mo...nely people tend to share their loneliness with ot...onnected people moves to the fringes of social net...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2Loneliness can be contagious 2Loneliness can be contagious 3World Day to Combat Desertification focuses on human security 8869 1World Day to Combat Desertification focuses on human security 8869 2Quest Diagnostics Announces Final Tender Offer Results 12672 1Quest Diagnostics Announces Final Tender Offer Results 12672 2Quest Diagnostics Announces Final Tender Offer Results 12672 3Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 1Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 2Ocean Spray Teams Up With the American Heart Associations Go Red For Women and Its Go Red BetterU Program 49202 3
... cells within blood vessel walls move en masse ove... that the proteins driving cell behavior are doin...sible to group them according to a few discrete fu...iversity School of Medicine have shown that distin...ple activities involved in the cells, collective m...
.... World records tumbled at the Beijing Olympics. U...ecords, knocking tenths of a second off each. Peop...st few decades, which made marathon runner Mark De... century,s massive increase in population could ac...dered whether there are absolute limits on running...
... differentiations in the metabolic make-up of the ...ovember 28 in the open-access journal PLoS Geneti... Karsten Suhre, has conducted a genome-wide associ... variants in genes involved in the breakdown of fa...y can affect individuals, susceptibility to comple...
Other Biology News:Cell movements totally modular, Stanford study shows 2Cell movements totally modular, Stanford study shows 3100-meter sprint world record could go as low as 9.48 seconds 2Study identifies genetic variants giving rise to differences in metabolism 2
...loped for affinity capture of proteins from biolog...rfaces allow differential capture of proteins acco... chip has eight different spots, allowing side-by-...ded with a unique hydrophobic coating. Ciphergen's...
...r conventional PCR and thermal gradient applicatio...rmal cycler, which features a 96-well reaction mod...ble time, temperature, and protocol options, and b...ol. The system also includes PCR tubes, iTaq DNA p...
...loped for affinity capture of proteins from biolog...rfaces allow differential capture of proteins acco... chip has eight different spots, allowing side-by-...ded with a unique hydrophobic coating. Ciphergen's...
...ny-picking capabilities, 110-120 V, uses floating ...igonucleotides, carbohydrates, lipids, and other b...array applications. This system can also be used f... diameter and for inoculating 96- or 384-well micr...
Biology Products: